160 related articles for article (PubMed ID: 21211673)
1. Neurological complications in Fabry disease.
Dütsch M; Hilz MJ
Rev Med Interne; 2010 Dec; 31 Suppl 2():S243-50. PubMed ID: 21211673
[TBL] [Abstract][Full Text] [Related]
2. Enzyme replacement therapy improves function of C-, Adelta-, and Abeta-nerve fibers in Fabry neuropathy.
Hilz MJ; Brys M; Marthol H; Stemper B; Dütsch M
Neurology; 2004 Apr; 62(7):1066-72. PubMed ID: 15079003
[TBL] [Abstract][Full Text] [Related]
3. Small fiber dysfunction predominates in Fabry neuropathy.
Dütsch M; Marthol H; Stemper B; Brys M; Haendl T; Hilz MJ
J Clin Neurophysiol; 2002 Dec; 19(6):575-86. PubMed ID: 12488789
[TBL] [Abstract][Full Text] [Related]
4. Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease.
Schiffmann R; Floeter MK; Dambrosia JM; Gupta S; Moore DF; Sharabi Y; Khurana RK; Brady RO
Muscle Nerve; 2003 Dec; 28(6):703-10. PubMed ID: 14639584
[TBL] [Abstract][Full Text] [Related]
5. Neuropathy and Fabry disease: pathogenesis and enzyme replacement therapy.
Schiffmann R
Acta Neurol Belg; 2006 Jun; 106(2):61-5. PubMed ID: 16898255
[TBL] [Abstract][Full Text] [Related]
6. [Neurological aspects of Fabry disease].
Clavelou P; Besson G
Presse Med; 2007 Mar; 36 Spec No 1():1S65-8. PubMed ID: 17546771
[TBL] [Abstract][Full Text] [Related]
7. Neurological complications of Anderson-Fabry disease.
Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Arnao V; Licata G; Pinto A
Curr Pharm Des; 2013; 19(33):6014-30. PubMed ID: 23448452
[TBL] [Abstract][Full Text] [Related]
8. [Neurological manifestations of Fabry disease].
Mendióroz M; Fernández-Cadenas I; Montaner J
Rev Neurol; 2006 Dec 16-31; 43(12):739-45. PubMed ID: 17160925
[TBL] [Abstract][Full Text] [Related]
9. Small fibers in Fabry disease: baseline and follow-up data under enzyme replacement therapy.
Üçeyler N; He L; Schönfeld D; Kahn AK; Reiners K; Hilz MJ; Breunig F; Sommer C
J Peripher Nerv Syst; 2011 Dec; 16(4):304-14. PubMed ID: 22176145
[TBL] [Abstract][Full Text] [Related]
10. Functional and structural nerve fiber findings in heterozygote patients with Fabry disease.
Torvin Møller A; Winther Bach F; Feldt-Rasmussen U; Rasmussen A; Hasholt L; Lan H; Sommer C; Kølvraa S; Ballegaard M; Staehelin Jensen T
Pain; 2009 Sep; 145(1-2):237-45. PubMed ID: 19665302
[TBL] [Abstract][Full Text] [Related]
11. Fabry disease.
Toyooka K
Handb Clin Neurol; 2013; 115():629-42. PubMed ID: 23931807
[TBL] [Abstract][Full Text] [Related]
12. Enzyme replacement therapy in two Japanese siblings with Fabry disease, and its effectiveness on angiokeratoma and neuropathic pain.
Furujo M; Kubo T; Kobayashi M; Ohashi T
Mol Genet Metab; 2013 Nov; 110(3):405-10. PubMed ID: 23906479
[TBL] [Abstract][Full Text] [Related]
13. [Fabry disease : diagnosis and treatment].
Üçeyler N; Sommer C
Schmerz; 2012 Sep; 26(5):609-19. PubMed ID: 23052995
[TBL] [Abstract][Full Text] [Related]
14. [The neurological manifestations of Fabry disease. A review].
Firsov KV; Kotov AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(9):98-105. PubMed ID: 27735906
[TBL] [Abstract][Full Text] [Related]
15. Lower limb cold exposure induces pain and prolonged small fiber dysfunction in Fabry patients.
Hilz MJ; Stemper B; Kolodny EH
Pain; 2000 Feb; 84(2-3):361-5. PubMed ID: 10666542
[TBL] [Abstract][Full Text] [Related]
16. Enzyme replacement therapy and intraepidermal innervation density in Fabry disease.
Schiffmann R; Hauer P; Freeman B; Ries M; Scott LJ; Polydefkis M; Brady RO; McArthur JC; Wagner K
Muscle Nerve; 2006 Jul; 34(1):53-6. PubMed ID: 16583374
[TBL] [Abstract][Full Text] [Related]
17. Metronomic breathing shows altered parasympathetic baroreflex function in untreated Fabry patients and baroreflex improvement after enzyme replacement therapy.
Hilz MJ; Koehn J; Kolodny EH; Brys M; Moeller S; Stemper B
J Hypertens; 2011 Dec; 29(12):2387-94. PubMed ID: 21970939
[TBL] [Abstract][Full Text] [Related]
18. Neurological features of Fabry disease: clinical, pathophysiological aspects and therapy.
Bersano A; Lanfranconi S; Valcarenghi C; Bresolin N; Micieli G; Baron P
Acta Neurol Scand; 2012 Aug; 126(2):77-97. PubMed ID: 22428782
[TBL] [Abstract][Full Text] [Related]
19. [Neurological complications of Fabry-disease].
Vastagh I; Constantin T; Kéri A; Rudas G; Fekete G; Bereczki D
Ideggyogy Sz; 2011 Jan; 64(1-2):29-35. PubMed ID: 21428036
[TBL] [Abstract][Full Text] [Related]
20. [Utility of enzyme replacement therapy in Fabry disease].
Politei JM; Dubrovsky A
Med Clin (Barc); 2010 Apr; 134(9):402-5. PubMed ID: 20138313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
